BoyNextDoor
I hate liars
- Joined
- Apr 19, 2010
- Posts
- 14,158
Our Revolution is just heating up as Bernie continues to make regulating drug pricing part of the public policy conversation
Bernie Sanders requests info from Ariad Pharmaceuticals on its leukemia drug
The company drew anger after it raised the price of Iclusig for the fourth time in 2016 to a list price of nearly $199,000 a year. In the letter addressed to Ariad CEO Paris Panayiotopoulos, the two lawmakers said Ariad's "outrageous sales tactics" show that the company is "more concerned with its profit than with its patients."
Ariad May Not Be the Last to Feel the Bern
What's scary for other drugmakers is that this is more evidence they're still being watched, even as a contentious election season winds down. It also means the universe of pricing behavior under scrutiny is expanding.
Bernie Sanders requests info from Ariad Pharmaceuticals on its leukemia drug
The company drew anger after it raised the price of Iclusig for the fourth time in 2016 to a list price of nearly $199,000 a year. In the letter addressed to Ariad CEO Paris Panayiotopoulos, the two lawmakers said Ariad's "outrageous sales tactics" show that the company is "more concerned with its profit than with its patients."
Ariad May Not Be the Last to Feel the Bern
What's scary for other drugmakers is that this is more evidence they're still being watched, even as a contentious election season winds down. It also means the universe of pricing behavior under scrutiny is expanding.